Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


ANI Pharmaceuticals Announces FDA Acceptance Of Purified Cortrophin Gel Supplemental New Drug Application For Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, And Nephrotic Syndrome


Benzinga | Aug 31, 2021 06:51AM EDT

ANI Pharmaceuticals Announces FDA Acceptance Of Purified Cortrophin Gel Supplemental New Drug Application For Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, And Nephrotic Syndrome






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC